Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,006,936
-$658,303 QoQ
Shares Held
166,401
+0.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#685
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KLCM Advisors, Inc. holds $30,076,760 across 9 Drug Manufacturers - General names. PFE ranks #2 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
293,739 | $16,925,241 | |
| 2 | PFE |
Pfizer Inc
This page
|
166,401 | $4,006,936 | |
| 3 | ABBV |
AbbVie Inc.
|
10,009 | $2,518,664 | |
| 4 | JNJ |
Johnson & Johnson
|
8,607 | $2,185,919 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,218 | $1,698,513 | |
| 6 | LLY |
ELI LILLY & Co
|
1,147 | $1,375,746 | |
| 7 | OGN |
Organon & Co.
|
48,807 | $660,846 | |
| 8 | AMGN |
Amgen Inc
|
1,343 | $486,327 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,006,936 | 166,401 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $4,665,239 | 166,141 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $4,103,968 | 164,818 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $4,454,388 | 174,819 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,365,720 | 180,104 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $4,677,840 | 184,603 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,032,581 | 189,694 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $3,811,687 | 131,710 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,600,242 | 128,672 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,993,307 | 179,939 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $5,003,500 | 173,793 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $3,293,980 | 99,306 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $3,442,161 | 93,843 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,966,372 | 97,215 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,717,206 | 33,513 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,296,346 | 29,624 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,410,314 | 26,899 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,480,259 | 28,593 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $11,146,573 | 188,765 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $8,496,496 | 197,547 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $16,563,740 | 422,976 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $16,914,120 | 466,854 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $15,570,004 | 422,983 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $15,101,704 | 411,491 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $14,258,261 | 436,032 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $15,291,101 | 468,478 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||